BREAST CANCER TRIPLE NEGATIVE

Clinical trials for BREAST CANCER TRIPLE NEGATIVE explained in plain language.

Never miss a new study

Get alerted when new BREAST CANCER TRIPLE NEGATIVE trials appear

Sign up with your email to follow new studies for BREAST CANCER TRIPLE NEGATIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 1

New drug combo tested for Tough-to-Treat breast cancer

Disease control Not yet recruiting

This study is testing whether adding the drug olaparib to the chemotherapy temozolomide works better than temozolomide alone to control advanced triple-negative breast cancer. It will enroll 40 patients whose cancer has a specific genetic feature (MGMT methylation) and has worsen…

Matched conditions: BREAST CANCER TRIPLE NEGATIVE

Phase: PHASE2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

BREAST CANCER TRIPLE NEGATIVE

Get alerted when new BREAST CANCER TRIPLE NEGATIVE trials appear

New drug combo tested for Tough-to-Treat breast cancer